Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Washington,
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Atlanta, GA
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Houston, TX
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Anaheim, CA
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Cerritos, CA
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Cerritos, CA
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Culver City, CA
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Culver City, CA
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Garden Grove, CA
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Los Angeles, CA
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Norwalk, CA
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Norwalk, CA
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
San Bernardino, CA
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
San Bernardino, CA
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Torrance, CA
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
North Miami, FL
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
North Miami, FL
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Chicago, IL
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Marlton, NJ
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Marlton, NJ
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Glen Oaks, NY
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Rochester, NY
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Raleigh, NC
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Clinical Research Facility
mi
from
Dayton, OH
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated:  7/8/2015
Research Site
mi
from
Glenside,
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
Status: Enrolling
Updated: 7/8/2015
Research Site
mi
from
Glenside,
Click here to add this to my saved trials
Work Activity Augmented by Cognitive Rehabilitation for Schizophrenia
Work Activity Augmented by Cognitive Rehabilitation: Continuation and Follow-up
Status: Enrolling
Updated:  7/13/2015
VA Connecticut Healthcare System
mi
from
West Haven, CT
Work Activity Augmented by Cognitive Rehabilitation for Schizophrenia
Work Activity Augmented by Cognitive Rehabilitation: Continuation and Follow-up
Status: Enrolling
Updated: 7/13/2015
VA Connecticut Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
Clinical Research Facility
mi
from
Anaheim, CA
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
Clinical Research Facility
mi
from
Cerritos, CA
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
mi
from
Cerritos, CA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
Clinical Research Facility
mi
from
Garden Grove, CA
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
Clinical Research Facility
mi
from
San Diego, CA
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
Clinical Research Facility
mi
from
San Diego, CA
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
Clinical Research Facility
mi
from
Tampa, FL
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
Clinical Research Facility
mi
from
Hoffman Estates, IL
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
Clinical Research Facility
mi
from
St. Charles, MO
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
mi
from
St. Charles, MO
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
Clinical Research Facility
mi
from
St. Louis, MO
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
Clinical Research Facility
mi
from
North Platte, NE
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
mi
from
North Platte, NE
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
Clinical Research Facility
mi
from
Memphis, TN
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
Clinical Research Facility
mi
from
Dallas, TX
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
Clinical Research Facility
mi
from
Richmond, VA
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  7/20/2015
mi
from
Barranquilla,
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 7/20/2015
mi
from
Barranquilla,
Click here to add this to my saved trials
Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics
Evaluation of Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotic Medications
Status: Enrolling
Updated:  7/20/2015
Bronx Psychiatric Center
mi
from
Bronx, NY
Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics
Evaluation of Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotic Medications
Status: Enrolling
Updated: 7/20/2015
Bronx Psychiatric Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics
Evaluation of Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotic Medications
Status: Enrolling
Updated:  7/20/2015
Buffalo Psychiatric Center
mi
from
Buffalo, NY
Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics
Evaluation of Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotic Medications
Status: Enrolling
Updated: 7/20/2015
Buffalo Psychiatric Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
Safety and Tolerability of BI 409306 in Patients With Schizophrenia
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 409306 Film-coated Tablets Given Orally q.d. for 14 Days in Patients With Schizophrenia (Randomized, Parallel-group, Double-blind, Placebo-controlled Study)
Status: Enrolling
Updated:  7/21/2015
Boehringer Ingelheim Investigational Site
mi
from
Austin, TX
Safety and Tolerability of BI 409306 in Patients With Schizophrenia
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 409306 Film-coated Tablets Given Orally q.d. for 14 Days in Patients With Schizophrenia (Randomized, Parallel-group, Double-blind, Placebo-controlled Study)
Status: Enrolling
Updated: 7/21/2015
Boehringer Ingelheim Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Smoking Cessation for Veterans With Severe and Persistent Mental Illness
Randomized Trial of a Smoking Cessation Program for Persons With SMI
Status: Enrolling
Updated:  7/28/2015
Washington DC VA Medical Center, Washington, DC
mi
from
Washington,
Smoking Cessation for Veterans With Severe and Persistent Mental Illness
Randomized Trial of a Smoking Cessation Program for Persons With SMI
Status: Enrolling
Updated: 7/28/2015
Washington DC VA Medical Center, Washington, DC
mi
from
Washington,
Click here to add this to my saved trials
Smoking Cessation for Veterans With Severe and Persistent Mental Illness
Randomized Trial of a Smoking Cessation Program for Persons With SMI
Status: Enrolling
Updated:  7/28/2015
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Smoking Cessation for Veterans With Severe and Persistent Mental Illness
Randomized Trial of a Smoking Cessation Program for Persons With SMI
Status: Enrolling
Updated: 7/28/2015
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness
CBT for PTSD and SMI in Community Mental Health Centers
Status: Enrolling
Updated:  8/7/2015
Medical University of South Carolina
mi
from
Charleston, SC
Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness
CBT for PTSD and SMI in Community Mental Health Centers
Status: Enrolling
Updated: 8/7/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness
CBT for PTSD and SMI in Community Mental Health Centers
Status: Enrolling
Updated:  8/7/2015
South Carolina Department of Mental Health
mi
from
Columbia, SC
Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness
CBT for PTSD and SMI in Community Mental Health Centers
Status: Enrolling
Updated: 8/7/2015
South Carolina Department of Mental Health
mi
from
Columbia, SC
Click here to add this to my saved trials
Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia
Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia
Status: Enrolling
Updated:  8/11/2015
Durham VAMC
mi
from
Durham, NC
Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia
Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia
Status: Enrolling
Updated: 8/11/2015
Durham VAMC
mi
from
Durham, NC
Click here to add this to my saved trials
The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes
The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes
Status: Enrolling
Updated:  8/18/2015
University of Colorado Denver
mi
from
Aurora, CO
The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes
The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes
Status: Enrolling
Updated: 8/18/2015
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Nonconvulsive Electrotherapy: a Proof-of-concept Trial
Nonconvulsive Electrotherapy: a Proof-of-concept Trial
Status: Enrolling
Updated:  8/21/2015
University of Maryland Medical Center
mi
from
Baltimore, MD
Nonconvulsive Electrotherapy: a Proof-of-concept Trial
Nonconvulsive Electrotherapy: a Proof-of-concept Trial
Status: Enrolling
Updated: 8/21/2015
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia
A Single-center, Randomized, Double-blind, Flexible-dosage, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia
Status: Enrolling
Updated:  8/21/2015
Glendale Adventist Medical Center
mi
from
Glendale, CA
A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia
A Single-center, Randomized, Double-blind, Flexible-dosage, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia
Status: Enrolling
Updated: 8/21/2015
Glendale Adventist Medical Center
mi
from
Glendale, CA
Click here to add this to my saved trials
Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia
Effect of Repetitive Transcranial Magnetic Stimulation (RTMS) on Resting State Brain Activity in Schizophrenia
Status: Enrolling
Updated:  8/27/2015
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia
Effect of Repetitive Transcranial Magnetic Stimulation (RTMS) on Resting State Brain Activity in Schizophrenia
Status: Enrolling
Updated: 8/27/2015
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Effects of Transcranial Direct Current Stimulation in Individuals With Schizophrenia
Effects of Transcranial Direct Current Stimulation in Individuals With Schizophrenia
Status: Enrolling
Updated:  8/31/2015
Department of Neurology
mi
from
Baltimore, MD
Effects of Transcranial Direct Current Stimulation in Individuals With Schizophrenia
Effects of Transcranial Direct Current Stimulation in Individuals With Schizophrenia
Status: Enrolling
Updated: 8/31/2015
Department of Neurology
mi
from
Baltimore, MD
Click here to add this to my saved trials
Omega-3 Dietary Supplements in Schizophrenia
Detecting Which Patients With Schizophrenia Will Improve With Omega-3 Treatment
Status: Enrolling
Updated:  8/31/2015
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Omega-3 Dietary Supplements in Schizophrenia
Detecting Which Patients With Schizophrenia Will Improve With Omega-3 Treatment
Status: Enrolling
Updated: 8/31/2015
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia
Status: Enrolling
Updated:  9/1/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia
Status: Enrolling
Updated: 9/1/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials